全文获取类型
收费全文 | 543624篇 |
免费 | 35679篇 |
国内免费 | 26030篇 |
专业分类
耳鼻咽喉 | 3951篇 |
儿科学 | 11370篇 |
妇产科学 | 7107篇 |
基础医学 | 56661篇 |
口腔科学 | 7645篇 |
临床医学 | 64921篇 |
内科学 | 80498篇 |
皮肤病学 | 4766篇 |
神经病学 | 33968篇 |
特种医学 | 22544篇 |
外国民族医学 | 224篇 |
外科学 | 61285篇 |
综合类 | 71921篇 |
现状与发展 | 87篇 |
一般理论 | 31篇 |
预防医学 | 45257篇 |
眼科学 | 13332篇 |
药学 | 49654篇 |
433篇 | |
中国医学 | 24902篇 |
肿瘤学 | 44776篇 |
出版年
2024年 | 1281篇 |
2023年 | 5481篇 |
2022年 | 14454篇 |
2021年 | 18324篇 |
2020年 | 14445篇 |
2019年 | 11722篇 |
2018年 | 33048篇 |
2017年 | 28277篇 |
2016年 | 29504篇 |
2015年 | 17691篇 |
2014年 | 21740篇 |
2013年 | 19789篇 |
2012年 | 35045篇 |
2011年 | 52099篇 |
2010年 | 39646篇 |
2009年 | 28648篇 |
2008年 | 40356篇 |
2007年 | 42332篇 |
2006年 | 20603篇 |
2005年 | 21315篇 |
2004年 | 15906篇 |
2003年 | 16429篇 |
2002年 | 12415篇 |
2001年 | 8799篇 |
2000年 | 8724篇 |
1999年 | 8558篇 |
1998年 | 5495篇 |
1997年 | 5294篇 |
1996年 | 4041篇 |
1995年 | 3810篇 |
1994年 | 3231篇 |
1993年 | 2083篇 |
1992年 | 2460篇 |
1991年 | 2210篇 |
1990年 | 1914篇 |
1989年 | 1632篇 |
1988年 | 1336篇 |
1987年 | 1221篇 |
1986年 | 976篇 |
1985年 | 704篇 |
1984年 | 387篇 |
1983年 | 291篇 |
1982年 | 166篇 |
1981年 | 170篇 |
1980年 | 153篇 |
1979年 | 156篇 |
1978年 | 81篇 |
1974年 | 61篇 |
1938年 | 62篇 |
1932年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Valerie Iles 《Health care analysis》2016,24(2):105-118
This paper takes a somewhat slant perspective on flourishing and care in the context of suffering, death and dying, arguing that care in this context consists principally of ‘acts of work and courage that enable flourishing’. Starting with the perception that individuals, society and health care professionals have become dulled to death and the process of dying in Western advanced health systems, it suggests that for flourishing to occur, both of these aspects of life need to be faced more directly. The last days of life need to be ‘undulled’. Reflections upon the experiences of the author as carer and daughter in the face of her mother’s experience of death are used as basis for making suggestions about how care systems and professionals might better assist people in dealing with ‘the most grown up thing’ humans ever do, which is to die. 相似文献
22.
23.
24.
骨碎补是历代临床常用中药,具有疗伤止痛、补肾强骨、消风祛斑等功效。其主要含黄酮、苯丙素、三萜、酚酸及其苷等类化学成分,现代研究表明骨碎补具有抗骨质疏松、促进骨折愈合、促软骨再生、护牙健齿、保护肾功能、抗炎、防治中毒性耳聋、降血脂等多种生物活性,开发前景广阔。本文对近年来骨碎补的化学成分、药理作用及临床应用研究进行综述,以期为骨碎补的进一步深入系统的研究和开发利用提供依据。 相似文献
25.
Haochu Li Xiaoming Li Lai Sze Tso Shan Qiao Eleanor Holroyd Yuejiao Zhou 《Vulnerable children and youth studies》2016,11(2):173-179
In HIV/AIDS research, few studies to date have evaluated ways to improve parental HIV disclosure practices using feedback from HIV-negative children who have recently experienced this event. We conducted semi-structured in-depth interviews with 20 children (aged 6–15) who were partially to fully aware of their parents’ HIV status in rural Guangxi, China. Of the 20 children, eight children who were of older age (11.38 years in average) endorsed parental HIV disclosure, five discouraged it and seven expressed uncertainty. Children’s different experiences and attitudes towards disclosure were seen to be associated with their family dynamics (especially the parent–child relationship), social support and care, experiences of stigma and discrimination, psychosocial suffering, comprehension of the disease and the children’s age. Our study contributes to building a child-centered comprehensive understanding for Chinese parental HIV disclosure. It is imperative that counselors and community advocates assess and help parents achieve optimal readiness preceding disclosure of their illness to their HIV-negative children. 相似文献
26.
27.
28.
29.
30.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献